Vaishali Pharma Share Price Today | Stock Price & Vaishali Pharma Share Screener
As of October 5, 2026, the live Vaishali Pharma share price (NSE: VAISHALI) is ₹8.28, down 1.19% from the previous close, with shares trading between ₹8.22 and ₹8.95 in today's trading session, and a 52-week range of ₹4.88–₹10.26. Check VAISHALI price range for the annual price range and momentum. Use the Vaishali Pharma stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Vaishali Pharma opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Vaishali Pharma Share Price Chart
Track the current stock price of Vaishali Pharma with an interactive chart. Analyse VAISHALI share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Vaishali Pharma stock quote in one place.
The quote of ₹8.28 sits between the 52-week low of ₹4.88 and the 52-week high of ₹10.26, and the latest session moved -1.19% from the previous close.
Vaishali Pharma Company Profile - Fundamental Screener
Screen Vaishali Pharma company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for VAISHALI shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE972X01022.
Company Details
Classification
Identifiers and Leadership
Vaishali Pharma Balance Sheet Screener
Screen VAISHALI balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2026, total assets were ₹123, up from ₹110 in 2025.
Latest statistics put total assets at ₹123 and shareholder funds at ₹69, with a leverage ratio of 0.24.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
Assets |
||||||||||
| Total Assets | 123 | 110 | 80 | 79 | 82 | 86 | 66 | 69 | 64 | 45 |
| Current Assets | 113 | 105 | 75 | 73 | 76 | 81 | 61 | 63 | 59 | 40 |
| Fixed Assets | 2 | 2 | 2 | 2 | 1 | 1 | 2 | 1 | 1 | 1 |
Liabilities |
||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 6 | 5 | 4 | 6 | 3 | 4 | 4 | 5 | 3 | 4 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity |
||||||||||
| Total Equity | 69 | 65 | 43 | 41 | 26 | 22 | 21 | 21 | 21 | 4 |
| Share Capital | 26 | 26 | 11 | 11 | 11 | 11 | 11 | 7 | 7 | 3 |
| Reserves & Surplus | 43 | 39 | 32 | 30 | 16 | 12 | 11 | 15 | 14 | 1 |
Vaishali Pharma Income Statement Screener - Profit & Revenue Analysis
Screen Vaishali Pharma income statement and profit fundamentals. Analyze VAISHALI quarterly results. Vaishali Pharma reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For 2026-Mar, revenue was ₹28 and net profit was ₹0, equal to earnings per unit of ₹0.03, at an operating margin of -1%.
In that period expenses were ₹27, interest cost ₹1 and tax ₹0. The next period listed, 2026-Jun, shows revenue of ₹24 and net profit of ₹2.
| Item | 2026-Mar | 2026-Jun | 2025-Jun | 2025-Sept | 2025-Dec |
|---|---|---|---|---|---|
Revenue and Expenses | |||||
| Revenue | 28 | 24 | 25 | 34 | 26 |
| Expenses | 27 | 21 | 22 | 32 | 23 |
Operating Costs and Margins | |||||
| EBITDA | 1 | 2 | 2 | 2 | 2 |
| Operating Profit % | -1.00% | 6.00% | 6.00% | 4.00% | 6.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 |
| Interest | 1 | 0 | 0 | 0 | 1 |
Profit and Earnings | |||||
| Profit Before Tax | 0 | 2 | 2 | 2 | 2 |
| Tax | 0 | 0 | 1 | 1 | 1 |
| Net Profit | 0 | 2 | 1 | 1 | 1 |
| EPS | 0.03 | 0.12 | 0.10 | 0.09 | 0.10 |
Vaishali Pharma Cash Flow Screener - Liquidity Fundamentals
Screen VAISHALI cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2026-March, operating activities generated ₹0.
Over the same period, investing activities used ₹5 and financing activities provided ₹5.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations and Investing | ||||||||||
| Operating Activities | 0 | -18 | 1 | 1 | 1 | 2 | 3 | 4 | -10 | 1 |
| Investing Activities | -5 | 0 | 1 | 0 | -1 | 0 | 0 | 0 | 1 | 1 |
Financing and Net Cash | ||||||||||
| Financing Activities | 5 | 19 | -1 | -2 | 0 | -2 | -3 | -4 | 9 | -1 |
| Net Cash Flow | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
Vaishali Pharma Shareholding Pattern Screener
See Vaishali Pharma shareholding pattern with promoter, FII, and DII holdings. Check Vaishali Pharma promoter holding and ownership changes for VAISHALI on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Mar, promoters held 31.61%, foreign institutions 0.00%, domestic institutions 0.00% and the public 62.32%, spread across 26,534 shareholders.
The shareholder count was 26,534 in 2026-Mar, compared with 26,671 in 2026-Jun.
| Item | 2026-Mar | 2026-Jun | 2026-Jul | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 31.61% | 31.61% | 30.54% | 26.32% | 26.32% | 26.32% | 31.61% | 26.32% |
Institutional Investors | ||||||||
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Government, Public and Others | ||||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 62.32% | 62.79% | 60.70% | 65.24% | 65.88% | 67.25% | 62.75% | 62.93% |
| Other Holding | 6.07% | 5.60% | 8.76% | 8.44% | 7.80% | 6.43% | 5.65% | 10.74% |
| Shareholder Count | 26,534 | 26,671 | 26,697 | 28,874 | 28,682 | 27,752 | 27,752 | 9,390 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Vaishali Pharma. Vaishali Pharma dividend yield can be compared with peers and other stocks in the market.
Vaishali Pharma Stock Index Membership - Nifty & Sensex
See which indices include Vaishali Pharma stock. Check VAISHALI index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
Complete Index List
Vaishali Pharma Market Events Screener - Corporate Actions
Get Vaishali Pharma corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Vaishali Pharma stock events that may affect VAISHALI share price, along with derivatives, futures and options activity and sector gainers.
12 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated August 14, 2026, with a record date of August 14, 2026.
It is followed by Quarterly Result Announcement dated May 30, 2026 and Quarterly Result Announcement dated February 13, 2026.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-08-14 | 2026-08-14 | Quarterly Result Announcement | NA | 7.49% |
| 2026-05-30 | 2026-05-30 | Quarterly Result Announcement | NA | 0.71% |
| 2026-02-13 | 2026-02-13 | Quarterly Result Announcement | NA | 0.38% |
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | -1.85% |
| 2025-08-11 | 2025-08-11 | Quarterly Result Announcement | NA | -4.93% |
| 2025-05-28 | 2025-05-28 | Quarterly Result Announcement | NA | -1.61% |
| 2025-02-06 | 2025-02-06 | Quarterly Result Announcement | NA | 4.37% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -8.12% |
| 2024-10-15 | 2024-10-15 | Split | 2:10 | 19.65% |
| 2024-10-15 | 2024-10-15 | Bonus | 1:1 | -2.49% |
| 2024-09-27 | 2024-09-27 | Annual General Meeting | NA | 19.02% |
| 2019-10-17 | Bonus | 3:5 | - |
Vaishali Pharma Competitors Screener - Peer Stocks Comparison
Screen VAISHALI competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 441,478 | 36.83 | 61,674 | 12.69% | 11,565 | 47.42 |
| Divis Laboratories | 248,160 | 86.00 | 11,067 | 13.95% | 2,568 | 58.71 |
| Torrent Pharmaceuticals | 182,729 | 86.72 | 13,886 | 20.34% | 2,138 | 48.14 |
| Zydus Life Science | 116,030 | 25.96 | 27,658 | 17.64% | 5,026 | 61.81 |
| Cipla | 109,788 | 33.29 | 29,045 | 2.24% | 3,870 | 44.03 |
| Laurus Labs | 106,928 | 98.39 | 6,868 | 22.01% | 890 | 58.00 |
| Mankind Pharma | 103,637 | 50.84 | 14,636 | 14.85% | 1,938 | 64.24 |
| Dr Reddys Laboratories | 103,459 | 32.77 | 35,059 | 3.90% | 4,158 | 69.59 |
| Aurobindo Pharma | 96,497 | 26.41 | 34,145 | 5.56% | 3,503 | 54.69 |
| Lupin | 93,612 | 16.97 | 29,039 | 26.75% | 5,356 | 34.02 |
Vaishali Pharma Company Announcements - News & Reports Screener
Screen VAISHALI latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated September 30, 2026.
The next most recent announcements are dated September 30, 2026 and September 4, 2026.
| Date | Update | Actions |
|---|---|---|
| 2026-09-30 | Shareholders meeting | - |
| 2026-09-30 | Shareholders meeting | - |
| 2026-09-04 | General Updates | - |
| 2026-09-03 | Copy of Newspaper Publication | - |
| 2026-09-01 | Shareholders meeting | - |
| 2026-09-01 | Record Date | - |
| 2026-09-01 | General Updates | - |
| 2026-08-17 | Copy of Newspaper Publication | - |
| 2026-08-14 | Outcome of Board Meeting | - |
| 2026-08-14 | Resignation of Director/KMP/SMP | - |
| 2026-08-14 | Resignation of Director/KMP/SMP | - |
| 2026-08-14 | Resignation of Director/KMP/SMP | - |
| 2026-08-14 | Resignation | - |
| 2026-07-15 | Certificate under SEBI (Depositories and Participants) Regulations, 2018 | - |
| 2026-07-09 | Outcome of Board Meeting | - |
| 2026-07-04 | Shareholders meeting | - |
| 2026-07-03 | General Updates | - |
| 2026-07-03 | Allotment of Securities | - |
| 2026-07-02 | Outcome of Board Meeting | - |
| 2026-06-25 | Trading Window | - |
Frequently Asked Questions
How is the company valued right now?
The current quote is ₹8.28, within a 52-week range of ₹4.88 to ₹10.26. The P/E ratio is 24.68 and the P/B ratio is 1.58, with earnings per unit of ₹0.31. Market capitalisation stands at ₹113.80 Cr. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.
About This Data
Quotes are sourced from the NSE. Key statistics were last updated on October 6, 2026. This page covers 10 balance sheet periods, 5 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.